Related references
Note: Only part of the references are listed.Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis
Maya H. Buch et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Progressive multifocal leukoencephalopathy
Robert Weissert
JOURNAL OF NEUROIMMUNOLOGY (2011)
Recurrent Fevers, Cough, and Pulmonary Opacities in a Middle-Aged Man
Philippe R. Bauer et al.
CHEST (2010)
Rituximab-induced fatal interstitial pneumonitis: case report
C. Vulsteke et al.
LEUKEMIA & LYMPHOMA (2010)
High incidence of Pneumocystis jirovecii pneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone
Sarah Kamel et al.
LEUKEMIA & LYMPHOMA (2010)
Rituximab-Associated Neutropenia
Kieron Dunleavy et al.
SEMINARS IN HEMATOLOGY (2010)
Severe Pulmonary Adverse Effects in Lymphoma Patients Treated with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) Regimen Plus Rituximab
Kyu-Hyoung Lim et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2010)
Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing interstitial pneumonia in patients with non-Hodgkin lymphoma
Hiroo Katsuya et al.
LEUKEMIA & LYMPHOMA (2009)
Rituximab (B-Cell Depleting Antibody) Associated Lung Injury (RALI): A Pediatric Case and Systematic Review of the Literature
Martin Bitzan et al.
PEDIATRIC PULMONOLOGY (2009)
A case of rituximab-induced interstitial pneumonitis observed in systemic lupus erythematosus
Jun Kishi et al.
RHEUMATOLOGY (2009)
ABCG2 Q141K polymorphism is associated with chemotherapy-induced diarrhea in patients with diffuse large B-cell lymphoma who received frontline rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone chemotherapy
In-Suk Kim et al.
CANCER SCIENCE (2008)
Increased incidence of interstitial pneumonia by CHOP combined with rituximab
Daisuke Ennishi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma
Robert Marcus et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Interstitial pneumonitis during rituximab-containing chemotherapy for non-Hodgkin lymphoma
Xin Liu et al.
LEUKEMIA & LYMPHOMA (2008)
Rituximab-CHOP induced interstitial pneumonitis in patients with disseminated extranodal marginal zone B cell lymphoma
Kwang Min Kim et al.
YONSEI MEDICAL JOURNAL (2008)
Interstitial Pneumonitis and Alveolar Hemorrhage Complicating Use of Rituximab
Gustavo A. Heresi et al.
RESPIRATION (2008)
FCGR3A gene polymorphisms may correlate with response to frontline R-CHOP therapy for diffuse large B-cell lymphoma
Dong Hwan Kim et al.
BLOOD (2006)
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:: a randomised controlled trial by the MabThera International Trial (MInT) Group
Michael Pfreundschuh et al.
LANCET ONCOLOGY (2006)
Fatal interstitial pneumonitis related to rituximab-containing regimen
Y Herishanu et al.
CLINICAL LYMPHOMA & MYELOMA (2006)
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone:: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group
W Hiddemann et al.
BLOOD (2005)
Tolerability and safety of rituximab (MabThera®)
E Kimby
CANCER TREATMENT REVIEWS (2005)
Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy
H Ghesquieres
ANNALS OF ONCOLOGY (2005)
A case of interstitial pneumonia induced by rituximab therapy
J Hiraga et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2005)
Interstitial pneumonitis following rituximab therapy for immune thrombocytopenic purpura (ITP)
R Swords et al.
AMERICAN JOURNAL OF HEMATOLOGY (2004)
Interstitial lung disease associated with drug therapy
P Camus et al.
BRITISH JOURNAL OF CANCER (2004)
Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphoma
DT Alexandrescu et al.
LEUKEMIA & LYMPHOMA (2004)
Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcγRIIIa gene
G Cartron et al.
BLOOD (2002)
CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
B Coiffier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Share Paper
